Literature DB >> 15908376

Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.

Timothy F Murphy1, Aimee L Brauer, Christoph Aebi, Sanjay Sethi.   

Abstract

Moraxella catarrhalis is an important respiratory tract pathogen, causing otitis media in children and lower respiratory tract infections in adults with chronic obstructive pulmonary disease (COPD). Adults with COPD make antibody responses to M. catarrhalis following infection, but little is known about the identity of the antigens to which these antibodies are directed. In this study, 12 serum samples obtained from adults with COPD who had cleared M. catarrhalis from the respiratory tract following infection and who had developed new serum immunoglobulin G (IgG) to their infecting strain were subjected to a series of assays to identify the antigens to which potentially protective antibodies were directed. Sera were adsorbed with intact bacterial cells, and antibodies were eluted from the surfaces of the bacteria. Analysis by flow cytometry established that adsorption and elution effectively detected antibodies specifically directed to surface-exposed epitopes. Immunoblot assays of adsorbed and eluted serum fractions were performed with purified outer membranes and purified lipooligosaccharide of homologous infecting strains and with a series of mutants deficient in expression of individual outer membrane proteins (OMPs). While heterogeneity in antibody responses among individuals was observed, five major OMPs, UspA1, UspA2, Hag, TbpB, and OMP CD, were identified as targets of antibodies to surface epitopes in the majority of adults with COPD who cleared the organism. These results have important implications in understanding human immune responses to M. catarrhalis and in elucidating the elements of a protective immune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908376      PMCID: PMC1111810          DOI: 10.1128/IAI.73.6.3471-3478.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

2.  Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy; L C Bartos
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

3.  Interactions between viruses and bacteria in patients with chronic bronchitis.

Authors:  C B Smith; C Golden; M R Klauber; R Kanner; A Renzetti
Journal:  J Infect Dis       Date:  1976-12       Impact factor: 5.226

4.  Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease.

Authors:  Faris Bakri; Aimee L Brauer; Sanjay Sethi; Timothy F Murphy
Journal:  J Infect Dis       Date:  2002-02-05       Impact factor: 5.226

5.  Role of infection in chronic bronchitis.

Authors:  D W Gump; C A Phillips; B R Forsyth; K McIntosh; K R Lamborn; W H Stouch
Journal:  Am Rev Respir Dis       Date:  1976-04

6.  Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Charmaine Kirkham; Dai-Fang Liu; Sanjay Sethi
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen.

Authors:  S Sethi; S L Hill; T F Murphy
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults.

Authors:  Patricia Stutzmann Meier; Nadja Heiniger; Rolf Troller; Christoph Aebi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children.

Authors:  Patricia Stutzmann Meier; Simone Freiburghaus; Andrea Martin; Nadja Heiniger; Rolf Troller; Christoph Aebi
Journal:  Pediatr Infect Dis J       Date:  2003-03       Impact factor: 2.129

10.  A study of infective and other factors in exacerbations of chronic bronchitis.

Authors:  V U McHardy; J M Inglis; M A Calder; J W Crofton; I Gregg; D A Ryland; P Taylor; M Chadwick; D Coombs; R W Riddell
Journal:  Br J Dis Chest       Date:  1980-07
View more
  27 in total

1.  Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 2.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

3.  Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Authors:  Raina T Gergova; Ianko D Iankov; Iana H Haralambieva; Ivan G Mitov
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

4.  Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2015-09-21       Impact factor: 3.641

5.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Jennifer L Sedillo; Maria Labandeira-Rey; Cassie A Laurence; Wei Wang; James A Richardson; Lauren O Bakaletz; Eric J Hansen
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

7.  Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.

Authors:  Timothy F Murphy; Aimee L Brauer; Melinda M Pettigrew; Eric R LaFontaine; Hervé Tettelin
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

8.  Virulence-associated trimeric autotransporters of Haemophilus parasuis are antigenic proteins expressed in vivo.

Authors:  Alex Olvera; Sonia Pina; Marta Pérez-Simó; Simone Oliveira; Albert Bensaid
Journal:  Vet Res       Date:  2009-12-10       Impact factor: 3.683

Review 9.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

10.  Moraxella catarrhalis expresses an unusual Hfq protein.

Authors:  Ahmed S Attia; Jennifer L Sedillo; Wei Wang; Wei Liu; Chad A Brautigam; Wade Winkler; Eric J Hansen
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.